Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Feb;93(2):1045-1056.
doi: 10.1002/jmv.26389. Epub 2020 Aug 13.

The effect of smoking on COVID-19 severity: A systematic review and meta-analysis

Affiliations
Meta-Analysis

The effect of smoking on COVID-19 severity: A systematic review and meta-analysis

Rohin K Reddy et al. J Med Virol. 2021 Feb.

Abstract

Various comorbidities represent risk factors for severe coronavirus disease 2019 (COVID-19). The impact of smoking on COVID-19 severity has been previously reported in several meta-analyses limited by small sample sizes and poor methodology. We aimed to rigorously and definitively quantify the effects of smoking on COVID-19 severity. MEDLINE, Embase, CENTRAL, and Web of Science were searched between 1 December 2019 and 2 June 2020. Studies reporting smoking status of hospitalized patients with different severities of disease and/or at least one clinical endpoint of interest (disease progression, intensive care unit admission, need for mechanical ventilation, and mortality) were included. Data were pooled using a random-effects model. This study was registered on PROSPERO: CRD42020180920. We analyzed 47 eligible studies reporting on 32 849 hospitalized COVID-19 patients, with 8417 (25.6%) reporting a smoking history, comprising 1501 current smokers, 5676 former smokers, and 1240 unspecified smokers. Current smokers had an increased risk of severe COVID-19 (risk ratios [RR]: 1.80; 95% confidence interval [CI]: 1.14-2.85; P = .012), and severe or critical COVID-19 (RR: 1.98; CI: 1.16-3.38; P = .012). Patients with a smoking history had a significantly increased risk of severe COVID-19 (RR: 1.31; CI: 1.12-1.54; P = .001), severe or critical COVID-19 (RR: 1.35; CI: 1.19-1.53; P < .0001), in-hospital mortality (RR: 1.26; CI: 1.20-1.32; P < .0001), disease progression (RR: 2.18; CI: 1.06-4.49; P = .035), and need for mechanical ventilation (RR: 1.20; CI: 1.01-1.42; P = .043). Patients with any smoking history are vulnerable to severe COVID-19 and worse in-hospital outcomes. In the absence of current targeted therapies, preventative, and supportive strategies to reduce morbidity and mortality in current and former smokers are crucial.

Keywords: coronavirus; epidemiology; pandemics; pathogenesis; respiratory tract; virus classification; zoonoses.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
Flow diagram of selection of included studies
Figure 2
Figure 2
A, Forest plot showing the effect of current smoking on severe COVID‐19. B, Forest plot showing the effect of current smoking on severe or critical COVID‐19. C, Forest plot showing the effect of current smoking on mortality. COVID‐19, coronavirus disease 2019
Figure 3
Figure 3
A, Forest plot showing the effect of a smoking history on severe COVID‐19. B, Forest plot showing the effect of a smoking history on severe or critical COVID‐19. C, Forest plot showing the effect of a smoking history on mortality. COVID‐19, coronavirus disease 2019

References

    1. WHO . Coronavirus disease (COVID‐19) Situation Report ‐ 190. July 28 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed July 29, 2020.
    1. Johns Hopkins University and Medicine Coronavirus Resource Center . COVID‐19 World Map. July 29 2020. https://coronavirus.jhu.edu/map.html. Accessed July 29, 2020.
    1. Wu Z, McCoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. 10.1001/jama.2020.2648 - DOI - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062. - PMC - PubMed
    1. Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID‐19: a rapid systematic review and meta‐analysis. PLoS One. 2020;15:e0233147. - PMC - PubMed

MeSH terms